Wird geladen...
SU6668 modulates prostate cancer progression by downregulating MTDH/AKT signaling pathway
Prostate cancer is the second leading cause of cancer deaths among men in Western counties and has increased in incidence also in China in recent years. Although diagnosis modalities for primary prostate cancer have markedly improved, there are still no effective therapies for metastatic prostate ca...
Gespeichert in:
| Veröffentlicht in: | Int J Oncol |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
D.A. Spandidos
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5403372/ https://ncbi.nlm.nih.gov/pubmed/28339027 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2017.3926 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|